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Abstract

The side effects of Finasteride are currently a subject of controversy. Some studies
report minor or acceptable adverse effects, which decrease after a variable period of time so
that they do not necessitate terminating Finasteride administration. However, several clinical
and neuro-endocrine studies show that some adverse effects persist indefinitely in the form of
post-Finasteride syndrome, even after the drug cessation.
This paper presents a possible explanation for these inconsistent findings. First, the
study design of either informing or not informing patients prior therapy about possible adverse
effects can influence the incidence and magnitude of reported adverse effects. Second,
structural and information dichotomies of the brain generate four distinct neuronal networks,
which are activated through specific cerebral neuromodulators and that are able to support
four distinct minds within an individual body.
As a conclusion, the “mind psychophysiology” and the corresponding mental
impairments differ across individuals, such that not only the prediction of adverse effects
should be addressed from a more individualized medical perspective, but also the therapeutic
strategies could be tailored to the four distinct mental profiles described. It is a personalized
approach that would be applicable to several interrelated domains of neuroscience, like
psychology, psychiatry and sexuality. Finally, this perspective may represent a starting point
for a more individualized understanding of mental events, perhaps even a step forward in the
understanding of the mind-body problem.

Keywords: Finasteride, adverse reactions, personalized medicine, psychology, psychiatry, sexuality,
post-Finasteride syndrome

Acne conglobata is a rare, severe form of acne vulgaris characterized by the presence of comedones,
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papules, pustules, nodules and sometimes hematic or meliceric crusts, located on the face, trunk, neck, arms
and buttocks.
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Introduction
Finasteride (a 5-α reductase inhibitor) is currently an
extensively-used medication for two distinct conditions
strongly related to androgens: male androgenic alopecia
and benign prostatic hyperplasia. Therapeutic results are
maintained only as long as the drug is administered,
most patients losing the medical and/ or aesthetic
benefits from therapy once the drug is terminated.
Moreover, during the therapeutic phase, some patients
report variable adverse effects which either diminish
during or after therapy in some patients (1), or persist
indefinitely in others in the form of post-finasteride
syndrome (2).
The most frequent manifestations of post-finasteride
syndrome are represented by sexual disorders and
mental/ psychological impairments. Interestingly,
cognition and sexuality show several interrelations
which become apparent not only during normal
functioning but also during disease states. Both
cognition and sexuality, for example, depend on the
same set of environmental stimuli and centrally are
presumably supported by a common/ mental operator,
namely the attentional focus. The existing
psychophysiologic/
neuroendocrine
interrelations
between cognition and sexuality are bidirectional —
cognition affecting sexual response and vice versa— and
to a large extent are responsible for the persistence of
Finasteride adverse effects after treatment cessation (3).
Even though some data suggest that Finasteride side
effects (occurring during the drug administration) should
be differentiated from post-finasteride syndrome
(registered after treatment cessation) (4), they are
relatively similar and both are characterized by mental
impairment (anhedonia, depression, lack of mental
concentration, suicidal ideations, etc.) and sexual
disorders (decreased libido, impotence/ erectile
dysfunction, ejaculation disorders, etc.). Other adverse
effects include gynecomastia, secondary infertility,
chronic fatigue, increased fat deposition, etc (3-5).

men, while tamoxifen—an estrogen modulator—induces
adverse reactions especially in left-handed men (6, 7).
These different effects appear to result from a lateralized
neurosteroid activation process in the brain. As a
consequence, finasteride adverse effects could be
predicted based on this structural dichotomy of the brain,
using such lateralized functions as hand preference and
sexual orientation as pretreatment delineating elements
(8, 9). Beyond this structural dichotomy, the human
brain also presents a functional/ informational
dichotomy, with sexual hormones acting primarily upon
concrete mental functioning, and sexual pheromones
modulating abstract mental functioning (10). Thus,
patients having a strong pheromonal activation of
sexuality would present a low or minimal risk for
developing
adverse
reactions
to
Finasteride
administration.
As a preliminary conclusion, the incidence and
magnitude of Finasteride side effects depend to a great
extent on the structural and informational dichotomies of
the brain (11), which delineate within the brain four
distinct minds (12, 13). The structural dichotomy was
partly addressed by our recent report indicating that
biological parameters such as hand preference and
sexual orientation are linked to brain lateralization (8, 9).
The informational dichotomy will be investigated in the
near future using specific psychological tests/ tools that
enable differentiation between abstract and concrete
mental functioning.
This paper presents the most relevant findings
regarding the distribution of Finasteride side effects
among patients, and argues for the necessity to adopt an
individualized approach to the administration of
Finasteride in male androgenic alopecia and benign
prostatic hyperplasia.

Discussion
Concerns related to Finasteride side effects

Five years ago, a study performed on thirty-three
Based on previous reports, finasteride appears to men (with right-handed participants having lower overall
decrease sexual function predominantly in right handed IIEF scores than left-handed participants) found that left126

Finasteride as a model for personalized medicine

handed men showed better post-treatment scores than
right-handed men on IIEF-assessed sexual functioning
following Finasteride administration. Interaction effects
were found on five subscales—erectile function (EF),
intercourse satisfaction (IS), orgasmic function (OF),
sexual desire (SD), and overall satisfaction (OS)—such
that left-handed men showed increased post-treatment
scores whereas right-handed men showed decreased
post-treatment scores (6). Two years later, a pilot study
revealed that administration of Tamoxifen for male
breast cancer induced sexual side effects especially in
left handed participants. Thus, a main effect for
tamoxifen was found on all five subscales, with
tamoxifen decreasing sexual functioning in both groups
of men. Interaction effects were found on three IIEF
subscales (OF, SD, and OS), such that left-handed men
showed greater decreased sexual function under
tamoxifen than right-handed men (7).
Studies related to finasteride have shown that the
frequency and magnitude of adverse effects are higher
when patients are informed about possible adverse
effects and lower or absent (even ignored) when not
informed (14). As a consequence, the reported adverse
effects depend on multiple subjective and objective
factors, including study design, the structural dichotomy
of the brain (lateralization), and the informational
dichotomy of the brain. Not surprisingly, recent reports
have advanced the idea that hand preference and sexual
orientation (both strongly related to brain lateralization)
might be used as possible predictors for finasteride
adverse effects in male androgenic alopecia (8, 9). Other
data suggest that beyond just predictability, hand
preference and sexual orientation might also be used for
therapeutic guidance on Finasteride administration,
taking into account both structural and informational
dichotomies of the brain (11).
Increasing concern for the predictability and
management of Finasteride side effects is justified by the
severity of some of its adverse events (2). Thus, recent
data indicate that androgenic alopecia and benign
prostatic hyperplasia can lead to depressive symptoms
and suicidal thoughts among former finasteride users

who develop persistent sexual side effects (15-18).
These side effects are yet under evaluation, a relatively
difficult process due to the fact that the pathophysiology
of mental and sexual functions (often affected in
tandem) are not fully documented. Moreover, the postfinasteride syndrome is only recently recognized as a
distinct clinical entity, requiring further study with
respect to the psycho-neuroendocrine processes involved
(3, 4).
In support of this, a very recent study has shown that
some patients treated with finasteride for male pattern
hair loss develop post-finasteride syndrome, in the form
of persistent sexual side effects, anxiety, depression, and
cognitive impairments. These persistent effects are
associated with changes in steroid levels in cerebrospinal
fluid, represented by decreased levels of pregnenolone,
progesterone, dihydroprogesterone, dihydrotestosterone,
17beta-estradiol,
and
increased
levels
of
dehydroepiandrosterone, testosterone and 5alphaandrostane-3alpha,17beta-diol (19). These neuroendocrine abnormalities are complicated by the finding
that many former users of finasteride experience
decreased alcohol tolerance due to cerebral interference
of Finasteride with GABAA receptors (20).
Even though some finasteride side effects appear
severe, suggested resolution varies from an extreme
therapeutic approach (involving replacement of
Finasteride with the more active compound Dutasteride)
(21), to an exclusive pharmaco-vigilance perspective
imposing prudence and drug substitution (18). Other
authors consider that finasteride should be retained as a
valid therapeutic approach for androgenic alopecia, due
to two important reasons (22). First, dihydrotestosterone
has important physiological roles within the body (23)
such that partial suppression of this hormone (specific
for Finasteride) is preferred over complete suppression
(the case of Dutasteride). In addition, replacement of
Finasteride with Dutasteride might exacerbate adverse
effects. Yet, the therapeutic action of Finasteride could
be enhanced using a synergistic compound, such as
minoxidil for androgenic alopecia (24). Second, even if
Finasteride side effects are more frequent or severe than
127
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initially assumed, these adverse effects could be
anticipated through a screening of patients on a priori
criteria (8, 9). To understand these criteria, namely why
some men respond with severe adverse effects and
others do not, it is necessary to understand the structural
and informational dichotomies of the brain.
Informational dichotomy of the brain

right) hemibrains. If data reception is ensured by both
hemibrains, processing of information occurs usually in
only one hemibrain (defined as the dominant hemibrain).
Accordingly, the opposite/ non-dominant hemibrain
would support only the neurological connection (inputs/
outputs) between dominant hemibrain and peripheral
receptors/ effectors (26). This asymmetric functioning of
the brain has been demonstrated for multiple cerebral
functions (hand preference, language, memory,
affection, sexuality, etc.) and is ensured through the
intervention of different neuromodulators that direct
environmental information towards either the left or the
right hemibrain (26). In the absence of this lateralization,
the two distinct hemibrains would receive and process
distinct responses to the same internal (memory/
imagination) or external data, a competitive situation
that would be physiologically and psychologically
counterproductive due to the possibility of conflicting
outputs (26, 28).

The classical input system for information coursing
to the brain is related to the dorsal system of attention,
with environmental stimuli/data being transmitted to the
thalamus, the somatic cortex, and, further, the autonomic
nervous system (ANS). The ANS supports autonomic
processing of data/information as well as elaboration of
specific responses, which are externalized in the form of
motor/ verbal events through the pyramidal motor
system. From a psychological perspective, this circuit of
information supports the concrete mind. In parallel with,
yet mutually exclusive of, this concrete mind is the
abstract mind, supported by the ventral system of
Structural and informational dichotomies of the
attention, receiving therefore data through the ventral
brain
hypothalamic input route (25). From here information is
sent first to the autonomic nervous system of the brain
Based on such lateralized functioning, estrogens
and subsequently to the somatic nervous system of the would modulate environmental inputs especially toward
brain (25, 26).
the right and concrete hemibrain, while androgens would
channel the same environmental information/ inputs
Recent data suggest that sexual hormones activate
toward the left and concrete hemibrain (11). For this
the concrete mind, while sexual pheromones activate the
reason, administration of antiestrogens such as
parallel, mutually exclusive, abstract mind (11, 27).
Tamoxifen induces sexual impairment especially in left
Thus persons depending on sexual pheromones for
handed men, while administration of Finasteride or
activation should be unaffected by antihormonal
Bicalutamide induces sexual impairment predominantly
compounds. Due to limited space herein, the psychoin right handed men (6, 7, 29).
physiological elements delineating abstract and concrete
minds are discussed in a forthcoming paper. Various
In a similar lateralized manner, female sexual
psychological
tests/assessments
should
enable pheromones would activate (in heterosexual men)
identification of individuals with a concrete especially the right and abstract hemibrain (right
psychological profile, specifically those individuals hippocampus, right parahippocampal gyrus, etc.). In
having an increased risk for adverse effects to contrast, male sexual pheromones would activate in
finasteride.
homosexual men predominantly the left and abstract
hemibrain (the left angular gyrus, left caudate nucleus,
Structural dichotomy of the brain (lateralization)
etc.). Imaging studies show that heterosexual men and
The human brain is structurally divided by the homosexual women (lesbians) present a rightward
median plane into two opposite/ symmetric (left and volumetric cerebral asymmetry (their connections being
128
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more widespread from the right amygdala), while psycho-physiologic profiles (12, 13). These neuronal
homosexual men and heterosexual women display more networks are generally incompatible with one another,
widespread connections from the left amygdala (30-34). being activated through the intervention of distinct
(cognitive or sexual) neuromodulators. As a
The importance of an individualized approach to the
consequence, the “mind psychophysiology,” therapeutic
administration of Finasteride
approach, and possible adverse effects to drugs
According to previous findings, the “mind interfering with the brain should be addressed in a more
psychophysiology” and its corresponding mental individualized manner, taking into account the mind
impairments differ across individuals, not only resulting (structural/ informational) diversity described in this
in differential adverse effects as described, but also paper.
suggesting the need for individualized therapeutic
Structural diversity was addressed through
strategies in the future. This approach might serve as one
individual elements strongly related to the lateralization
starting point for taking a more individualized approach
to the understanding of mental events, and furthermore process of the brain, like hand preference and sexual
may represent a step forward in unraveling the mind- orientation. Informational diversity should become
quantifiable through specific psychological tools useful
body problem.
for patient screening/ allocation to a specific (abstract
Specific to the current topic, aggregation of subjects
and concrete) mind profile responsive to either sexual
(according to specific individual parameters) in groups
hormones or pheromones.
having either predictably high or low risks for specific
adverse effect might represent one step toward this more
While abstract ideas are able to exert control over
personalized medical approach. In other words, our biological/physical existence, yet unexplained is the
administration of Finasteride should be acceptable to manner in which these abstract-immaterial data interfere
those having a low risk for developing adverse effects. with the material/physical nature of the brain. Several
But those falling into the high risk category for Finasteride side effects (depression, low libido, etc.) are
finasteride side effects should avoid taking the drug, strongly related to our conscious domain/ attentional
especially given that some adverse effects persist after focus, so a better understanding of these adverse effects
treatment ceases and no specific measures/consensus may inevitably lead to a better understanding of the
exists for treatment of post-finasteride syndrome.
mind psycho-physiology.

Conclusions

References

Finasteride side effects are generally related to
1. Welk B, McArthur E, Ordon M, Anderson KK,
several domains of neuroscience, including psychology,
Hayward J, Dixon S. Association of Suicidality and
psychiatry, and sexuality. Unfortunately, such
Depression With 5α-Reductase Inhibitors. JAMA
disciplines are not yet fully elaborated and integrated,
Intern Med. 2017; 177(5): 683-91. PMID:
such that the reporting of adverse effects induced by
28319231, DOI: 10.1001/jamainternmed.2017.0089
drugs acting on the brain (interfering with cerebral
2. Chiriacò G, Cauci S, Mazzon G, Trombetta C. An
neuromodulators) is not yet standardized.
observational retrospective evaluation of 79 young
Previously we presented in detail the structural (left
men with long-term adverse effects after use of
vs. right) and informational (abstract vs. concrete)
finasteride against androgenetic alopecia. Andrology.
dichotomies of the brain, dividing the brain into four
2016; 4(2): 245-50. PMID: 26763726, DOI:
10.1111/andr.12147
distinct neuronal networks able to generate four distinct
129

Ion G. Motofei et al.

3. Rowland DL, Motofei IG, Popa F, Constantin VD, 11. Motofei IG, Rowland DL, Manea M, Georgescu SR,
Vasilache A, Păunică I, Bălălău C, Păunică PG,
Păunică I, Sinescu I. Safety Profile of Finasteride:
Banu P, Păunică S. The postfinasteride syndrome; an
Distribution of Adverse Effects According to
Structural and Informational Dichotomies of the
overview. J Mind Med Sci. 2016; 3(2): 99-107.
Mind/Brain. Clin Drug Investig. 2017; 37(6): 511-7.
4. Manea M, Paunica I, Puiu GM, Manea CM.
PMID: 28161756, DOI: 10.1007/s40261-017-0501Finasteride side effects and post-Finasteride
8.
syndrome in male androgenic alopecia. J Mind Med
12. Motofei IG, Rowland DL, Paunica S, Tampa M,
Sci. 2015; 2(2): 142-9.
Georgescu SR. Lateralized sexual side effects of
5. Paunica S, Giurgiu M, Vasilache A, Paunica I,
Finasteride in subjects with androgenic alopecia. J
Motofei IG, Vasilache A, Dumitriu HT, Dumitriu
Invest Dermatol. 2014; 134: S69.
AS. Finasteride adverse effects and post-finasteride
syndrome; implications for dentists. J Mind Med Sci. 13. Gerogescu SR, Tampa M, Paunica S, Balalau C,
Constantin V, Paunica G, Motofei I. Distribution of
2016; 3(1): 71-9.
post-finasteride syndrome in men with androgenic
6. Motofei IG, Rowland DL, Georgescu SR, Baconi
alopecia. J Invest Dermatol. 2015; 135: S40.
DL, Dimcevici NP, Paunica S, Constantin VD,
Balalau C. A pilot study on the sexual side effects of 14. Mondaini N, Gontero P, Giubilei G, Lombardi G,
finasteride as related to hand preference for men
Cai T, Gavazzi A, Bartoletti R. Finasteride 5 mg and
undergoing treatment of male pattern baldness. BJU
sexual side effects: how many of these are related to
Int. 2013; 111(4 Pt B): E221-6. PMID: 23157321,
a nocebo phenomenon? J Sex Med. 2007: 4(6):
1708–12. PMID: 17655657, DOI: 10.1111/j.1743DOI: 10.1111/j.1464-410X.2012.11580.x
6109.2007.00563.x
7. Motofei IG, Rowland DL, Popa F, Bratucu E, Straja
D, Manea M, Georgescu SR, Paunica S, Bratucu M, 15. Irwig MS. Depressive symptoms and suicidal
Balalau C, Constantin VD. A Pilot Study on
thoughts among former users of finasteride with
Tamoxifen Sexual Side Effects and Hand Preference
persistent sexual side effects. J Clin Psychiatry.
in Male Breast Cancer. Arch Sex Behav. 2015; 44(6):
2012; 73(9): 1220-3. PMID: 22939118, DOI:
1589-94. PMID: 26108899, DOI: 10.1007/s1050810.4088/JCP.12m07887
015-0530-4
16. Traish AM, Hassani J, Guay AT, Zitzmann M,
8. Motofei IG, Rowland DL, Georgescu SR, Tampa M,
Hansen ML. Adverse side effects of 5α-reductase
Baconi D, Stefanescu E, Baleanu BC, Balalau C,
inhibitors therapy: persistent diminished libido and
Constantin V, Paunica S. Finasteride adverse effects
erectile dysfunction and depression in a subset of
in subjects with androgenic alopecia: A possible
patients. J Sex Med. 2011; 8(3): 872-84. PMID:
therapeutic approach according to the lateralization
21176115, DOI: 10.1111/j.1743-6109.2010.02157.x
process of the brain. J Dermatolog Treat. 2016;
17. Unger JM, Till C, Thompson IM Jr, Tangen CM,
27(6):
495-497.
PMID:
27046152,
DOI:
Goodman PJ, Wright JD, Barlow WE, Ramsey SD,
10.3109/09546634.2016.1161155
Minasian LM, Hershman DL. Long-term
9. Motofei IG, Rowland DL, Georgescu SR, Tampa M,
Consequences of Finasteride vs Placebo in the
Baleanu BC, Paunica S. Are hand preference and
Prostate Cancer Prevention Trial. J Natl Cancer Inst.
sexual orientation possible predicting factors for
2016; 108(12). pii: djw168. PMID: 27565902, DOI:
finasteride adverse effects in male androgenic
10.1093/jnci/djw168
alopecia? Exp Dermatol. 2016; 25(7): 557-8. PMID:
18. Ali AK, Heran BS, Etminan M. Persistent Sexual
26990657, DOI: 10.1111/exd.13003
Dysfunction and Suicidal Ideation in Young Men
10. Motofei IG, Rowland DL. Informational dichotomy
Treated
with
Low-Dose
Finasteride:
A
of the mind; the role of sexual neuromodulators. J
Pharmacovigilance Study. Pharmacotherapy. 2015;
Mind Med Sci. 2017; 4(1): 19-23. DOI:
35(7):
687-95.
PMID:
26133534,
DOI:
10.22543/7674.41.P1923
10.1002/phar.1612
130

Finasteride as a model for personalized medicine

19. Melcangi RC, Santi D, Spezzano R, Grimoldi M, 27. Motofei IG. A dual physiological character for
Tabacchi T, Fusco ML, Diviccaro S, Giatti S, Carrà
sexual function: libido and sexual pheromones. BJU
G, Caruso D, Simoni M, Cavaletti G. Neuroactive
Int. 2009; 104(11): 1702-8. PMID: 19466949, DOI:
steroid levels and psychiatric and andrological
10.1111/j.1464-410X.2009.08610.x
features in post-finasteride patients. J Steroid
28. Seizeur R, Magro E, Prima S, Wiest-Daesslé N,
Biochem Mol Biol. 2017; 171: 229-35. PMID:
Maumet C, Morandi X. Corticospinal tract
28408350, DOI: 10.1016/j.jsbmb.2017.04.003
asymmetry and handedness in right- and left-handers
20. Irwig MS. Decreased alcohol consumption among
by diffusion tensor tractography. Surg Radiol Anat.
former male users of finasteride with persistent
2013; 36(2): 111–24. PMID: 23807198, DOI:
sexual side effects: a preliminary report. Alcohol
10.1007/s00276-013-1156-7
Clin. Exp. Res. 2013; 37: 1823-6. PMID: 23763349,
29. Motofei IG, Rowland DL, Popa F, Kreienkamp D,
DOI: 10.1111/acer.12177
Paunica S. Preliminary study with bicalutamide in
21. Arif T, Dorjay K, Adil M, Sami M. Dutasteride in
heterosexual and homosexual patients with prostate
Androgenetic Alopecia: An Update. Curr Clin
cancer: a possible implication of androgens in male
Pharmacol. 2017; 12(1): 31-35. PMID: 28294070,
homosexual arousal. BJU Int. 2011; 108(1): 110-5.
PMID:
20955264,
DOI:
10.1111/j.1464DOI: 10.2174/1574884712666170310111125
410X.2010.09764.x
22. Motofei IG, Rowland DL, Baconi DL, Georgescu
SR, Paunică S, Constantin VD, Bălălău D, Paunică I, 30. Savic I, Berglund H, Lindström P. Brain response to
Bălălău C, Baston C, Sinescu I. Therapeutic
putative pheromones in homosexual men. Proc Natl
considerations related to Finasteride administration
Acad Sci USA. 2005: 102(20): 7356–61. PMID:
in male androgenic alopecia and benign prostatic
15883379, DOI: 10.1073/pnas.0407998102
hyperplasia. Farmacia 2017; (accepted for
31. Berglund H, Lindström P, Savic I. Brain response to
publication)
putative pheromones in lesbian women. Proc Natl
23. Ilangovan R, Sittadjody S, Balaganesh M,
Acad Sci USA 2006; 103(21): 8269–74. PMID:
Sivakumar R, Ravi Sankar B, Balasubramanian K,
16705035, DOI: 10.1073/pnas.0600331103
Srinivasan S, Subramanian C, Thompson DM,
32. Savic I, Lindström P. PET and MRI show
Queimado L, Srinivasan N. Dihydrotestosterone is a
differences in cerebral asymmetry and functional
determinant of calcaneal bone mineral density in
connectivity between homo- and heterosexual
men. J Steroid Biochem Mol Biol. 2009; 117: 132-8.
subjects. Proc Natl Acad Sci USA. 2008: 105(27):
PMID: 19732831, DOI:
9403–08.
PMID:
18559854,
DOI:
10.1016/j.jsbmb.2009.08.004
10.1073/pnas.0801566105
24. Hu R, Xu F, Sheng Y, Qi S, Han Y, Miao Y, Rui W, 33. Motofei IG. A dual physiological character for
Yang Q. Combined treatment with oral finasteride
cerebral mechanisms of sexuality and cognition:
and topical minoxidil in male androgenetic alopecia:
common somatic peripheral afferents. BJU Int.
a randomized and comparative study in Chinese
2011; 108(10): 1634-9. PMID: 21489118, DOI:
patients. Dermatol Ther. 2015; 28: 303-8.
10.1111/j.1464-410X.2011.10116.x
25. Motofei IG, Rowland DL. The ventral-hypothalamic 34. Hu SH, Wei N, Wang QD, Yan LQ, Wei EQ, Zhang
input route: a common neural network for abstract
MM, Hu JB, Huang ML, Zhou WH, Xu Y. Patterns
cognition and sexuality. BJU Int. 2014; 113(2): 296of brain activation during visually evoked sexual
303. PMID: 24053436, DOI: 10.1111/bju.12399
arousal differ between homosexual and heterosexual
men. AJNR Am J Neuroradiol. 2008: 29(10): 1890–
26. Motofei IG, Rowland DL. Structural dichotomy of
1896. PMID: 18768725, DOI: 10.3174/ajnr.A1260
the mind; the role of sexual neuromodulators. J
Mind Med Sci. 2016; 3(2): 131-140.

131

